Evidence map›Paper›PMID 36090389›Full record

ArticleRSC advances2022

Cardiac glycosides from

Hong-Ying Yang, Ya-Xiong Chen, Shangwen Luo, Yi-Lin He, Wei-Jiao Feng, Yue Sun, Jian-Jun Chen, Kun Gao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hong-Ying YangState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.
Ya-Xiong ChenState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.
Shangwen LuoState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.
Yi-Lin HeState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.
Wei-Jiao FengState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.
Yue SunState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.
Jian-Jun ChenState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.
Kun GaoState Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University 222 Tianshui South Road, Chengguan District Lanzhou Gansu 730000 People's Republic of China chenjj@lzu.edu.cn npchem@lzu.edu.cn.ORCID https://orcid.org/0000-0002-3856-3672
Lanzhou University · CNChinese Academy of Sciences · CNLanzhou Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac glycosides (CGs) are good candidates as drug leads in the treatment of cancer because of their structural diversities and potent biological activities. In this study, fifteen CGs including three new ones (1-3) were isolated from

Identifiers

PMID36090389
PMCPMC9380703
OpenAlexW4292064228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.